[
    [
        {
            "time": "2021-03-17",
            "original_text": "智飞生物：新冠疫苗紧急使用获得批准 商业化价值可期",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "紧急使用",
                    "商业化"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智飞生物：新冠疫苗紧急使用获得批准 商业化价值可期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-03-17",
            "original_text": "新冠疫苗海外获批 智飞生物3000亿市值能否保住？",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "海外获批",
                    "智飞生物",
                    "市值"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "新冠疫苗海外获批 智飞生物3000亿市值能否保住？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-17",
            "original_text": "首创证券给予智飞生物买入评级，公司简评报告：重组新冠疫苗获批紧急使用授权，自产疫苗矩阵再添重磅产品",
            "features": {
                "keywords": [
                    "首创证券",
                    "智飞生物",
                    "重组新冠疫苗",
                    "紧急使用",
                    "买入评级"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "首创证券给予智飞生物买入评级，公司简评报告：重组新冠疫苗获批紧急使用授权，自产疫苗矩阵再添重磅产品",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-17",
            "original_text": "渤海证券 - 医药行业周报：关注一季度业绩同比增长的优质个股【行业研究】",
            "features": {
                "keywords": [
                    "渤海证券",
                    "医药行业",
                    "一季度业绩",
                    "优质个股"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "渤海证券 - 医药行业周报：关注一季度业绩同比增长的优质个股【行业研究】",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-17",
            "original_text": "万联证券 - 智飞生物：代理+自研双轮驱动，打开长期成长空间【公司研究】",
            "features": {
                "keywords": [
                    "万联证券",
                    "智飞生物",
                    "代理",
                    "自研",
                    "长期成长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "万联证券 - 智飞生物：代理+自研双轮驱动，打开长期成长空间【公司研究】",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-17",
            "original_text": "A股史上首次蓝筹股泡沫破裂，6成私募反对抄底",
            "features": {
                "keywords": [
                    "蓝筹股",
                    "泡沫破裂",
                    "私募",
                    "抄底"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "股票市场"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股史上首次蓝筹股泡沫破裂，6成私募反对抄底",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]